Discovered by BIOTEC research team together with the Medicines for Malaria Venture (MMV), the patented P218 compound was designed based-on 3-dimensional structures of malaria protein target, dihydrofolate reductase, in order to circumvent mutations that had led to resistance to pyrimethamine, […]
Recent Posts
- FoodSERP Forum #1 Kicks Off, Showcasing Innovations in Healthy Flavored Coffee
07/18/2025 - FoodSERP Forum #2 Opens the Stage for Future Food Innovation
07/18/2025 - FAO Delegation and High-Level Representatives Visit BIOTEC to Strengthen Regional Collaboration on Plant Genetics, Bioeconomy and Aquaculture
07/13/2025